NFE2L2 and esophageal squamous cell carcinoma: Wang et al. explored 164 cases of ESCC with advanced disease undergoing treatment with chemoradiotherapy and showed that patients with high nuclear NFE2L2 expression exhibited lower ORR, PFS and OS compared with those with a low nuclear NFE2L2 expression [83].